ROLF A. CLASSON - Corporate Board Profile

ENZON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2003-10-28	Rolf A. Classon, has served as a director of the Company since January 1997... During the fiscal year ended June 30, 2003 the Company recorded an aggregate of $104,500 in Independent Directors Fees, a summary of which follows:... Rolf A. Classon 19,500
2004-10-28	Rolf A. Classon (1)(2)(3)(4)(5)(6) ......... 59 1997 Director (1) Member of the Compensation Committee (2) Member of Scientific Advisory Committee (3) Member of the Finance and Audit Committee (4) Member of the Executive Committee (5) Member of Governance and Nominating Committee (6) Member of the Strategic Planning Committee During the fiscal year ended June 30, 2004, the Company paid the following fees earned during the year ended December 31, 2003 and for the quarter ended March 31, 2004: Rolf Classon ................. 30,875 11,875 19,000 1,606 As of June 30, 2004, the Finance and Audit Committee was comprised of Robert LeBuhn (Chairman), Rolf Classon and Dr. Rosina Dixon. As of June 30, 2004, the Compensation Committee was comprised of Rolf Classon (Chairman), Dr. Rosina Dixon and Dr. David Golde. The Scientific Advisory Committee is comprised of Dr. Rosina Dixon (Chairperson), Robert LeBuhn and Rolf Classon. The Strategic Planning Committee is comprised of Rolf Classon, Robert LeBuhn and Dr. Rosina Dixon. The Governance and Nominating Committee is comprised of Dr. Rosina Dixon (Chairperson), Rolf Classon and Robert LeBuhn. The Executive Committee is comprised of Arthur Higgins (Chairman), Rolf Classon and Robert LeBuhn.
2006-04-12	Rolf A. Classon, age 60, has served as a director of the Company since January 1997. ... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro. ... The Compensation Committee currently consists of Dr. Ando (Chairman) and Messrs. Classon and Micati. ... The Executive Committee currently consists of Mr. Buchalter (Chairman), Dr. Ando, and Messrs. Classon and Micati. ... During the fiscal year ended June 30, 2005, the Company recorded the following fees earned: Rolf Classon $77,000 cash compensation ...
2007-04-10	Rolf A. Classon, age 61, has served as a director of the Company since January 1997. ... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro. ... The Compensation Committee currently consists of Dr. Ando (Chairman) and Messrs. Classon and Micati. ... The Executive Committee currently consists of Mr. Buchalter (Chairman), Dr. Ando, and Messrs. Classon and Micati. ... Director Compensation for fiscal year ended December 31, 2006: Rolf Classon total $131,434.
2008-04-16	Rolf A. Classon, age 62, has served as a director of the Company since January 1997. Mr. Classon is chairman of Hillenbrand Industries... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro... The Compensation Committee currently consists of Dr. Ando (Chairman) and Messrs. Classon and Micati... The Executive Committee currently consists of Mr. Buchalter (Chairman), Dr. Ando, and Messrs. Classon and Micati... Director compensation for fiscal year ended December 31, 2007: Rolf Classon total $145,222.
2009-04-13	Rolf A. Classon, has served as a director of the Company since January 1997... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro... The Compensation Committee currently consists of Dr. Ando (Chairman) and Messrs. Classon and Micati... Director compensation for fiscal year ended December 31, 2008: $208,069.
2010-06-10	Rolf A. Classon has served as a director of the Company since January 1997. Mr. Classon is chairman of Hill-Rom Holdings, Inc., a publicly-traded provider of health care technology. The Finance and Audit Committee currently consists of Mr. Salisbury (Chairman) and Messrs. Classon and LeBuhn. The Compensation Committee currently consists of Mr. Classon (Chairman), Dr. Denner and Messrs. Levy and Micati. The Executive Committee consists of Dr. Denner (Chairman), Professor Mulligan and Mr. Classon.